<DOC>
	<DOCNO>NCT00277069</DOCNO>
	<brief_summary>1 . Determine response rate regimen anthracycline taxane resistant cohort patient .</brief_summary>
	<brief_title>Phase I-II Study Carboplatin , Vinorelbine Capecitabine Patients With Metastatic Breast Cancer</brief_title>
	<detailed_description>1 . Determine response rate regimen anthracycline taxane resistant cohort patient . 2 . Determine maximum tolerate dose capecitabine combination vinorelbine carboplatin patient population . 3 . Determine time relapse administration regimen .</detailed_description>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<criteria>Patient must histological diagnosis breast cancer metastasis . The metastatic disease confirm biopsy clinically indicate . The patient must measurable evaluable disease . Age &gt; 18 year &lt; 75 year . The patient may receive prior therapy vinorelbine , capecitabine , carboplatinum , cisplatinum . The patient may receive herceptin previously . The patient must previously receive least one cycle chemotherapy . The patient must receive anthracycline taxane contain chemotherapy past . This may either adjuvant set metastatic disease . Resistance define progressive disease treatment , without initial response , relapse/progression within 6 month complete chemotherapy . Performance status &lt; 2 . At least 3 week must elapse since completion prior radiation therapy , chemotherapy , hormonal therapy . The patient must recover grade 34 associated toxicity time registration . Measurable evaluable disease must outside previous radiation field new lesion must present . Patients must receive concurrent hormonal , biologic therapy , radiation therapy measurable evaluable disease . The patient uncontrolled CNS disease . Laboratory parameter : ANC &gt; l500/ l , Platelets &gt; 100 000/ l , creatinine &lt; 2.0 , bilirubin &lt; 2.0 Informed consent .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Breast metastatic</keyword>
</DOC>